15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering IDEXX Laboratories Inc, 5 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $620.00 to $805.00, so the covering firms are broadly aligned. The average target of $734.38 sits 29% above the current $569.69. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $3.78 next quarter toward $16.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy563%
Hold338%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to IDEXX Laboratories Inc.
As of Jul, 5 of 8 firms rate IDXX a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
IDXX EPS & revenue forecast
EPS · NEXT QUARTER
$3.78
Range $3.70 – $3.86 · 11 analysts · +11% YoY
Next period, 11 analysts expect IDEXX Laboratories Inc to earn $3.78 a share (range $3.70 – $3.86), versus $3.40 a year earlier. Full-year consensus is $14.62, growing to $16.52 the year after.
REVENUE · NEXT QUARTER
$1.2B
Range $1.2B – $1.2B · 11 analysts · +8% YoY
Revenue is expected to reach $1.2B (range $1.2B – $1.2B), +7.8% year-over-year. Full-year consensus is $4.7B, rising to $5.1B next year.
Top analysts covering IDEXX Laboratories Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on IDXX.
#1
Jonathan Block
Stifel · Rank #172
Buy
$675.00+18.5% to target
Overall win rate
42%
+ Follow
#2
David Westenberg
Piper Sandler · Rank #227
Hold
$750.00+31.7% to target
Overall win rate
31%
+ Follow
#3
AA
Andrea Alfonso
UBS
Hold
$620.00+8.8% to target
Coverage
—
+ Follow
#4
Erin Wright
Morgan Stanley
Buy
$805.00+41.3% to target
Coverage
—
+ Follow
#5
GS
Glen Santangelo
Barclays
Buy
$800.00+40.4% to target
Coverage
—
+ Follow
IDXX stock forecast FAQ
What is IDXX's average 12-month price target?+
The 8 analysts with a live target average $734.38 for IDEXX Laboratories Inc over the next 12 months, ranging from a $805.00 high to a $620.00 low.
Is IDXX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 5 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for IDXX?+
The Street-high target is $805.00 (Morgan Stanley), and the Street-low is $620.00 (UBS). The average of all 8 active targets is $734.38.
How many Wall Street analysts cover IDXX?+
8 analysts have an active rating on IDEXX Laboratories Inc, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering IDXX?+
Among analysts who currently cover IDXX, Jonathan Block of Stifel has the strongest overall Quantellect track record (Rank #172). Their current call is Buy with a $675.00 target.
What is IDEXX Laboratories Inc's projected EPS for next quarter?+
The consensus estimate is $3.78 per share (range $3.70 – $3.86) across 11 analysts. Full-year EPS is projected at $14.62, rising to $16.52 the following year.
How much revenue is IDEXX Laboratories Inc expected to report next quarter?+
Consensus revenue is $1.2B (range $1.2B – $1.2B). Full-year revenue is projected at $4.7B, growing to $5.1B next year.
Have analysts been upgrading or downgrading IDXX lately?+
As of Jul, 5 of 8 firms rate IDXX a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their IDXX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
